NASDAQ:FULC Shareholder Alert: Lawsuit Alleges Securities Laws Violations by Fulcrum Therapeutics, Inc.
The Shareholders Foundation announced that an investor, who purchased shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC), filed a lawsuit over alleged violations of Federal Securities Laws by Fulcrum Therapeutics, Inc. in connection with certain allegedly false and misleading statements.
View full press release